Company intelligence / Profile preview

ProteoGenex

Ownership: Private
Development stage: Other

Overview

ProteoGenex is an innovative provider of high-quality, clinically annotated human biological specimens and associated information, serving academic, pharmaceutical, and biotechnology research primarily in the oncology and broader life sciences fields. The company operates a large biorepository and offers custom specimen collection, rapid turnaround, and extensive quality control for research customers globally. ProteoGenex does not develop or sell drugs, but enables biomedical research by supplying essential biospecimens.

Modalities: Biological specimensClinical data
Industry: Drug Discovery Services

Partnerships

Scientist.com (online procurement platform)

Beyond the preview

Go deeper on ProteoGenex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProteoGenex.

Explore the full profile